Medicinal Goats

They have four legs, fuzzy faces and udders full of milk.
To the uninitiated, they look like dairy goats. To GTC Biotherapeutics Inc., they’re cutting-edge drug-making machines.
A herd of goats has been genetically engineered to make a human protein in their milk that can prevent dangerous blood clots. If the drug is approved by the FDA, the barn door could swing open.
Los Angeles Times report HERE

FDA Lashes Out

Allergan Inc, the maker of Botox, said on Friday that the U.S. Food and Drug Administration has approved its eyelash-thickening drug Latisse.
The active ingredient in Latisse is bimatroprost, the same ingredient that is in Allergan’s glaucoma treatment Lumigan. Patients taking Lumigan found a side effect of the drug to be eyelash growth, prompting Allergan to study it for the new use.
Latisse is a once-daily prescription treatment that is applied to the base of the upper eyelash with a sterile, single-use-per-eye disposable applicator. Once treatment is stopped, eyelashes will gradually return to where they were prior to treatment.
Reuters report HERE